Alectinib synthetic routes

CAT#: 314205 | Name: Tasimelteon | CAS# 609799-22-6

Purchases for research

Description:

Tasimelteon (trade name Hetlioz) is a drug approved by the FDA solely for the treatment of non-24-hour sleep–wake disorder (often designated as N24HSWD) in totally blind adults. It is a selective agonist for the melatonin receptors MT1 and MT2 in the suprachiasmatic nucleus of the brain, similar to other members of the melatonin receptor agonist class of which ramelteon (2005) and agomelatine (2009) were the first approved.

Synthetic Routes

Tasimelteon - Synthetic Route 1

Tasimelteon - Synthetic Route 1

Synthetic reference

Mi, Senyang; Sun, Xinzhe; Wu, Chaogang; Zhang, Xingxian. A facile and practical synthesis of (-​)​-​tasimelteon. Journal of Chemical Research. Volume 40. Issue 11. Pages 667-669. Journal. (2016).

Tasimelteon - Synthetic Route 2

Tasimelteon - Synthetic Route 2

Synthetic reference

Wang, Wenbing; Meng, Xiangwei; Zhu, Jianrong; Zhang, Xingxian. An efficient and practical asymmetric synthesis of (-​)​-​tasimelteon. Synthetic Communications. Volume 49. Issue 1. Pages 129-135. Journal; Online Computer File. (2019).

Tasimelteon - Synthetic Route 3

Tasimelteon - Synthetic Route 3

Synthetic reference

Barreca, Giuseppe; Poggiali, Andrea. Process for the preparation of enantiomerically enriched dihydrobenzofurans and intermediate compounds obtained in the process. Assignee Quimica Sintetica, S. A., Spain. WO 2018149940. (2018).

Tasimelteon - Synthetic Route 4

Tasimelteon - Synthetic Route 4

Synthetic reference

Sun, Liquan; Zhao, Xinjun; Feng, Yanshu; Gao, Hanrong; Cornille, Fabrice; Canevotti, Renato. Method for synthesizing 2,3-dihydro-benzofuran-4-carbaldehyde and application in preparation of Tasimelteon. Assignee Dalian HonKai Chemical Technology Development Co., Ltd., Peop. Rep. China. CN 106588841. (2017).

Tasimelteon - Synthetic Route 5

Tasimelteon - Synthetic Route 5

Synthetic reference

: Zhang, Xingxian; Mi, Senyang. Preparation of optically pure Tasimelteon. Assignee Zhejiang University of Technology, Peop. Rep. China. CN 106543119. (2017).

Tasimelteon - Synthetic Route 6

Tasimelteon - Synthetic Route 6

Synthetic reference

Zhang, Chengzhi; Chakma, Justin; Laufer, Ralph. Preparation of cyclopropyl dihydrobenzofurans as modulators of melatonin receptors useful in disease therapy. Assignee Auspex Pharmaceuticals, Inc., USA. WO 2016109359. (2016).

Tasimelteon - Synthetic Route 7

Tasimelteon - Synthetic Route 7

Synthetic reference

Phadke, Deepak; Platt, Natalie M. Preparation of highly purified pharmaceutical grade tasimelteon. Assignee Vanda Pharmaceuticals Inc., USA. WO 2015123389. (2015).

Tasimelteon - Synthetic Route 8

Tasimelteon - Synthetic Route 8

Synthetic reference

: Xu, Xuenong. A kind of preparation method of tasimelteon. Assignee Suzhou Miracpharma Technology Co., Ltd., Peop. Rep. China. CN 104327022. (2015).

Tasimelteon - Synthetic Route 9

Tasimelteon - Synthetic Route 9

Synthetic reference

Catt, John D.; Johnson, Graham; Keavy, Daniel J.; Mattson, Ronald J.; Parker, Michael F.; Takaki, Katherine S.; Yevich, Joseph P. Preparation of N-acyl-2-arylcyclopropylmethylamines as melatonergics. Assignee Bristol-Myers Squibb Co., USA. WO 9825606. (1998).